At 72 weeks, average weight reduction was 20.2% with tirzepatide and 13.7% with semaglutide
Immunity 52:905909 Vos LM, Bruyndonckx R, Zuithoff NPA et al (2020) Lower respiratory tract infection in the community: associations between viral aetiology and illness course
Anche il pollame, come pollo e tacchino, contiene quantit significative di carnitina
Patients with palpable thyroid masses or suspicious symptoms may require further evaluation
Set realistic expectations - most people notice initial improvements around 2-4 weeks, with significant brightening effects appearing after 6-8 weeks of consistent use
Anyone with a BMI of 30 or above, or 27 with at least one weight-related comorbidity, meets the standard prescribing criteria for GLP-1 therapy